ICA Group Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$5.32K Sell
50
-29
-37% -$2.91K ﹤0.01% 577
2024
Q1
$7.64K Hold
79
﹤0.01% 946
2023
Q4
$7.98K Buy
+79
New +$7.63K ﹤0.01% 917
2023
Q3
Sell
-108
Closed -$10.9K 871
2023
Q2
$10.9K Hold
108
﹤0.01% 824
2023
Q1
$9.94K Hold
108
﹤0.01% 813
2022
Q4
$9.8K Buy
+108
New +$9.1K ﹤0.01% 831

Other funds holding NVS

ICA Group Wealth Management's NVS Position: Q2 2024 in Review

ICA Group Wealth Management reduced its Novartis (NVS) stake by 37% in Q2 2024, selling an estimated $2.91K and leaving 50 shares worth $5.32K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

ICA Group Wealth Management first reported a position in NVS in Q4 2022 and has held it in 6 quarters since. The position peaked at $10.9K in Q2 2023. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

  • ICA Group Wealth Management held 50 shares of Novartis worth $5.32K as of Q2 2024.
  • ICA Group Wealth Management sold 29 Novartis shares in Q2 2024, an estimated $2.91K.
  • Novartis made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #577 holding.
  • ICA Group Wealth Management first reported a position in Novartis in Q4 2022 and has held it in 6 quarters since.
  • ICA Group Wealth Management's Novartis position peaked at $10.9K in Q2 2023.
  • 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.